|
PBT2 finished 2011 taking 4 giant steps forward. First, it delivered shining results in a new study. Also, The Alzheimer's Discovery Foundation and Quintiles backed it with fresh funding. Next, it launched a big trial. Finally, Japan awarded it patents for Alzheimer's and Huntington's diseases. Find out more facts making PBT2 2012's most promising drug trial.
Read more »
|